Talis Biomedical Corporation Stock-Based Compensation
Talis Biomedical Corporation reported Stock-Based Compensation of $1.39 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2024-08-19
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for the quarter ending 2024-06-30 was $791.00K, a 26.49% decline year-over-year.
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for the quarter ending 2024-03-31 was $601.00K, a 49.20% decline year-over-year.
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $1.02M, a 20.44% decline year-over-year.
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $1.07M, a 17.28% decline year-over-year.
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for fiscal 2023 was $4.35M, a 18.95% decline from fiscal 2022.
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for fiscal 2022 was $5.37M, a 41.70% decline from fiscal 2021.
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for fiscal 2021 was $9.21M, a 149.99% increase from fiscal 2020.
- Talis Biomedical Corporation share-based payment arrangement, noncash expense for fiscal 2020 was $3.68M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $791.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $1.39M 10-Q · filed 2024-08-19 | $2.41M derived: sum of 3 quarters · filed 2024-08-19 | $3.48M derived: sum of 4 quarters · filed 2024-08-19 |
| 2024-03-31 | $601.00K 10-Q · filed 2024-05-08 | $1.62M derived: sum of 2 quarters · filed 2024-05-08 | $2.69M derived: sum of 3 quarters · filed 2024-05-08 | $3.77M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.09M derived: sum of 2 quarters · filed 2024-03-28 | $3.17M derived: sum of 3 quarters · filed 2024-08-19 | $4.35M 10-K · filed 2024-03-28 |
| 2023-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.15M derived: sum of 2 quarters · filed 2024-08-19 | $3.33M 10-Q · filed 2023-11-14 | $4.61M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $2.26M 10-Q · filed 2024-08-19 | $3.54M derived: sum of 3 quarters · filed 2024-08-19 | $4.84M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $1.18M 10-Q · filed 2024-05-08 | $2.46M derived: sum of 2 quarters · filed 2024-05-08 | $3.76M derived: sum of 3 quarters · filed 2024-05-08 | $5.01M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.58M derived: sum of 2 quarters · filed 2024-03-28 | $3.82M derived: sum of 3 quarters · filed 2024-03-28 | $5.37M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.54M derived: sum of 2 quarters · filed 2023-11-14 | $4.09M 10-Q · filed 2023-11-14 | $7.25M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.79M 10-Q · filed 2023-08-10 | $5.96M derived: sum of 3 quarters · filed 2023-08-10 | $8.43M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.54M 10-Q · filed 2023-05-11 | $4.71M derived: sum of 2 quarters · filed 2023-05-11 | $7.19M derived: sum of 3 quarters · filed 2023-05-11 | $8.98M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $5.64M derived: sum of 2 quarters · filed 2023-03-22 | $7.43M derived: sum of 3 quarters · filed 2023-03-22 | $9.21M 10-K · filed 2023-03-22 |
| 2021-09-30 | $2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.27M derived: sum of 2 quarters · filed 2022-11-03 | $6.04M 10-Q · filed 2022-11-03 | $7.60M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $3.56M 10-Q · filed 2022-08-02 | $5.13M derived: sum of 3 quarters · filed 2022-08-02 | $6.16M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $1.77M 10-Q · filed 2022-05-10 | $3.34M derived: sum of 2 quarters · filed 2022-05-10 | $4.37M derived: sum of 3 quarters · filed 2022-05-10 | $4.77M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.60M derived: sum of 2 quarters · filed 2022-03-15 | $3.00M derived: sum of 3 quarters · filed 2022-03-15 | $3.68M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-16 | $1.44M derived: sum of 2 quarters · filed 2021-11-16 | $2.12M 10-Q · filed 2021-11-16 | |
| 2020-06-30 | $407.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.09M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $681.00K 10-Q · filed 2021-05-13 |